| Old Articles: <Older 8191-8200 Newer> |
|---|
 |
The Motley Fool
June 30, 2005
Brian Gorman |
Teva's Non-Generic Side The drug company is working hard to cement its position in the market for multiple sclerosis meds. Investors, take note.   |
The Motley Fool
June 30, 2005
Timothy M. Otte |
WD-40 Caught in a Squeeze Cost pressures largely offset sales gains at the consumer products company. The fourth quarter is likely to show approximately flat earnings, with the full year looking like $1.50-$1.55, compared with $1.50 last year. |
The Motley Fool
June 30, 2005
Seth Jayson |
Fool by Numbers: ConAgra Q4 2005 One of America's largest packaged food companies released fourth-quarter 2005 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... |
The Motley Fool
June 30, 2005
Bill Mann |
Free Money for the Taking? Before going private, some small companies offer a chance for profits. This is a hidden corner of the stock market, and given the rising costs of SEC compliance, there will be plenty more companies deciding that being public just isn't worth it. |
The Motley Fool
June 30, 2005
W.D. Crotty |
Above the RIMM Research In Motion hits the high end of its first-quarter guidance. But as competitors crowd the field and pricing power inevitably declines, how far and how wide the can company can spread its technology? |
The Motley Fool
June 30, 2005
Tom Taulli |
IPOs Quiet No More The SEC can agree on some things, such as allowing companies to say more during an offering. So, how does this help investors? |
The Motley Fool
June 30, 2005
Tom Taulli |
The Scrushy Defense PR, highly paid attorneys, and ignorance: A recipe that worked quite well for HealthSouth's former CEO. The company currently trades on the Pink Sheets at around $5.80 per share. |
The Motley Fool
June 30, 2005
Stephen D. Simpson |
Biomet Wants Your Body Steady growth continues at the #4 orthopedics player. But Biomet shares haven't had a great year so far, hovering close to their 52-week low. |
The Motley Fool
June 30, 2005
Stephen D. Simpson |
I'm Drinking Stars! Constellation Brands continues to get the job done nicely. While good stock performance has taken a lot of the cheapness out of these shares, good growers in good businesses don't just fall out of trees. |
The Motley Fool
June 30, 2005
Rich Smith |
Painfully Obvious Stock Tips There's no law that says you have to take the good with the bad. As painful as most automakers look, there still might be some attractive investments in the sector. |
| <Older 8191-8200 Newer> Return to current articles. |
